The Federal Government announced on Tuesday that 3.92 million doses of the Oxford-AstraZeneca vaccine will be delivered by the end of July or early August.
Dr Faisal Shuaib, the Executive Director of the National Primary Healthcare Development Agency, announced this at a press conference in Abuja.
He said, “We now have information that Nigeria will get 3.92m doses of Oxford-Astrazeneca by end of July or early August.
“As we receive additional information on the exact dates in August, we will provide an update regarding timelines and details.”
Shuaib also revealed that new research from Public Health England found that the Indian variant of the virus, also known as the Delta variant B.1.617.2, is 92 percent susceptible to the Oxford-AstraZeneca drug.
He added, “It is therefore comforting to know that the vaccine used in Nigeria can protect against this variant that caused high morbidity and mortality in India.
“However, it underscores the need for us to ramp up our vaccination to more Nigerians.”